{
  "nct_id": "NCT95976257",
  "indication": "Rheumatoid Arthritis",
  "phase": "Phase 3",
  "sample_size": 314,
  "duration_weeks": 99,
  "dropout_rate": 0.18,
  "primary_endpoints": [
    "ACR20 response"
  ],
  "secondary_endpoints": [
    "Joint damage progression",
    "DAS28 score reduction"
  ],
  "blinding": "single-blind",
  "control_arm": "none",
  "outcome_summary": "Study benefit-risk profile does not support further development.",
  "success": false,
  "failure_reason": "Inadequate statistical power"
}